Literature DB >> 2415612

An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis.

P Ronco, T J Neale, C B Wilson, M Galceran, P Verroust.   

Abstract

There is evidence indicating that the glomerular Ig deposits of Heymann's nephritis (HN)--a model of epimembranous glomerulonephritis--may be formed at least in part in situ by binding of free circulating antibody with brush border (BB) antigen expressed by glomerular epithelial cells. In this work, we provide evidence that a 330-kD protein defined by seven monoclonal antibodies is responsible for HN. 1) Ig eluted from glomeruli of rats with HN induced classically with crude BB preparation bind specifically the 330-kD antigen; 2) passive immunization with monoclonal antibodies induces epimembranous glomerular Ig deposits; 3) active immunization with the 330-kD antigen induces proteinuric glomerulonephritis; 4) the 330-kD antigen was present in the nephritogenic preparation purified by Edgington, Glassock, and Dixon, because it was identified by the corresponding heterologous antisera. These results, obtained by a completely different approach, confirm and extend those of Kerjaschki and Farquhar and provide a link with the classical studies on HN.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2415612

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.

Authors:  R J Specht Grijp-Glandorf; E De Heer; C C Dekker-Nooren; M R Daha; L A Van Es
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IgGs by immunoelectron microscopy.

Authors:  G Dekan; A Miettinen; E Schnabel; M G Farquhar
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

Review 3.  Molecular development of immune deposits and proteinuria in Heymann nephritis.

Authors:  D Kerjaschki
Journal:  Clin Investig       Date:  1993-10

4.  Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities.

Authors:  Y Natori; I Hayakawa; S Shibata
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

5.  Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis.

Authors:  D Kerjaschki; R Horvat; S Binder; M Susani; G Dekan; P P Ojha; P Hillemanns; W Ulrich; U Donini
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

6.  Polyvalent antigen-antibody interactions are required for the formation of electron-dense immune deposits in passive Heymann's nephritis.

Authors:  L Allegri; E Brianti; F Chatelet; G C Manara; P Ronco; P Verroust
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

7.  Lymphocyte expression of a 90 kD brush border antigen.

Authors:  E H Van Leer; P Moullier; P Ronco; P Verroust
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

8.  Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.

Authors:  E H Van Leer; P Ronco; P Verroust; A M van der Wal; P J Hoedemaeker; E De Heer
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

9.  A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.

Authors:  Y Tsukada; K Ono; A Maezawa; S Yano; T Naruse
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  The detection and characterization of renal brush border antigen (gp108) in various rat tissues.

Authors:  Y Natori; I Hayakawa; S Shibata
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.